SCHEMBL12440940

SCHEMBL12440940

Cc1ccc(N2c3ccc(C)cc3Oc3cc(Br)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.41
ALDH1A1 P00352 3/20 0.38
ELANE P08246 2/20 0.36
F2 P00734 1/20 0.36
CTSG P08311 1/20 0.36
CMA1 P23946 1/20 0.36
CTRC Q99895 1/20 0.36
MGLL Q99685 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
CACNA1B Q00975 1/20 0.34
APBA1 Q02410 1/20 0.34
AGTR1 P30556 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
HBB P68871 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13328077 0.97 AHR (0.44) AHRALDH1A1ELANEF2CTSG
SCHEMBL28227794 0.93 ALDH1A1 (0.40) AHRALDH1A1ELANEF2CTSG
SCHEMBL16327689 0.91 AHR (0.43) AHRALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL12374353 0.90 ELANE (0.43) ALDH1A1ELANEF2CTSGCMA1
SCHEMBL13125131 0.89 AHR (0.46) AHRALDH1A1ELANEF2CTSG
SCHEMBL13429856 0.88 AHR (0.37) AHRALDH1A1ELANEF2CTSG
SCHEMBL23660862 0.86 AHR (0.50) AHRMGLLESR1ESR2MAPT
SCHEMBL29534796 0.86 AHR (0.50) AHRMGLLESR1ESR2MAPT
SCHEMBL12440945 0.86 AHR (0.36) AHRALDH1A1ELANEF2CTSG
SCHEMBL12514816 0.86 HSD17B10 (0.41) AHRALDH1A1ELANEF2CTSG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9318706-B2 Laminated structure, method for producing same, and electronic element comprising same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-19 US disclosed
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-21 US disclosed
US-7691494-B2 Electronic devices comprising organic iridium compositions GENERAL ELECTRIC COMPANY (US) 2010-04-06 US disclosed
US-20080026249-A1 Electronic devices comprising organic iridium compositions GENERAL ELECTRIC COMPANY 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME EPCAM, ITGA1, ITGB1 AHR 660/4885ALDH1A1 618/4885ELANE 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.